Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
| Episode | Date |
|---|---|
|
FDA Reporter Roundtable: A View From the News Desk
|
Mar 02, 2026 |
|
'Forever Chemicals' and Cosmetics Oversight in 2026
|
Feb 23, 2026 |
|
Medical Device Regulation, Compliance & Policy, Part 2: A Look at Europe & China
|
Feb 17, 2026 |
|
FDA's 2026 Food Priorities
|
Feb 09, 2026 |
|
Medical Device Regulation, Compliance & Policy, Part 1: LDTs in Focus
|
Feb 02, 2026 |
|
FDA's Evolving Approach to Medical Device Reviews
|
Jan 26, 2026 |
|
Inside FDA Pharma Policy Development
|
Jan 12, 2026 |
|
Year-End Review & Look Ahead
|
Dec 22, 2025 |
|
Deregulation, AI & More with Dr. Ritu Nalubola
|
Dec 08, 2025 |
|
Pharmaceutical Regulation, Compliance & Policy, Part 4: Dispute Resolution for Drugs and Biological Products
|
Dec 01, 2025 |
|
Key Issues Shaping Cosmetics and Personal Care Oversight
|
Nov 24, 2025 |
|
How Industry Is Adapting to FDA's Food Shifts
|
Nov 17, 2025 |
|
Pharmaceutical Regulation, Compliance & Policy, Part 3: A Close Look at Generic Drugs
|
Nov 10, 2025 |
|
Pharmaceutical Regulation, Compliance & Policy, Part 2: Navigating the New Enforcement Environment
|
Nov 03, 2025 |
|
Examining CDRH, Device Innovation & Agency Communication
|
Oct 27, 2025 |
|
A Look at FDA's Drug Review Reset
|
Oct 20, 2025 |
|
Pharmaceutical Regulation, Compliance & Policy, Part 1: The Evolving Regulatory Landscape of Rare Diseases
|
Oct 16, 2025 |
|
Unpacking OMUFA
|
Sep 15, 2025 |
|
FDA's Fight Against Ultraprocessed Foods
|
Sep 08, 2025 |
|
Dissecting the Direction of CDER and CBER with Paul Kim
|
Sep 02, 2025 |
|
Medical Device Oversight in a Changing Landscape
|
Aug 26, 2025 |
|
Vaccines, Pharmaceutical Policy & FDA's Next Moves
|
Aug 11, 2025 |
|
FDA's Past, Present & Future with John Taylor
|
Aug 07, 2025 |
|
The Top 3 Developments of 2025 in Pharma, Devices, Cosmetics & Food
|
Aug 06, 2025 |
|
Breaking Down Cosmetics Safety, Imports & MoCRA
|
Jun 02, 2025 |
|
AI, Medical Products & FDA, Part 3: AI in Drug & Device Commercialization
|
May 27, 2025 |
|
Homing in on Food Supply, Tariffs & Infant Formula
|
May 26, 2025 |
|
AI, Medical Products & FDA, Part 2: AI Discovery, Design & Development
|
May 01, 2025 |
|
Devices, Disruption & the Road Ahead
|
Apr 28, 2025 |
|
Breaking Down Pharma in the Current Environment
|
Apr 21, 2025 |
|
The State of Protection, Innovation & Communication at FDA
|
Apr 17, 2025 |
|
AI, Medical Products & FDA, Part 1: AI Overview in Life Sciences
|
Apr 15, 2025 |
|
Examining the Cosmetics Compliance and Enforcement Landscape
|
Apr 07, 2025 |
|
A New Era of Unprecedented Change
|
Apr 01, 2025 |
|
The Latest in FDA's Focus on Foods
|
Mar 31, 2025 |
|
What's Happening in Software and Device Regulation
|
Mar 17, 2025 |
|
The Evolution of Clinical Trials
|
Mar 03, 2025 |
|
Navigating FDA's Future: Janet Woodcock on the Evolving Regulatory Landscape
|
Feb 17, 2025 |
|
A Deep Dive Into MoCRA
|
Feb 10, 2025 |
|
Food Regulation and Safety Under the New Administration
|
Feb 03, 2025 |
|
The New-Look FDA: What's on the Horizon?
|
Jan 20, 2025 |
|
What's Coming in Device, Cybersecurity, and Digital Health Product Regulation
|
Jan 13, 2025 |
|
Key Pharmaceutical Regulation Issues for the New Administration
|
Jan 06, 2025 |
|
Trailer
|
Dec 11, 2024 |